PROVIDER PROFILE · NPI 1245234657
Sarah BelcherF.N.P.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
133
Unique beneficiaries
—
Total services
936
Distinct HCPCS
2
Medicare payment
$11K
Peer benchmark
Total Medicare services vs. 7,486 Nurse Practitioner providers in TN — top quintile (cohort median 320).
PRESCRIBING · PART D · 2024
Total Rx claims
118
Beneficiaries
—
Total drug cost
$2K
Distinct drugs
7
Brand share
16.1%
Top prescribed drugs
Montelukast Sodium27 claims
Hydroxychloroquine Sulfate23 claims
Albuterol Sulfate19 claims
Doxycycline Hyclate15 claims
Fluticasone Propionate12 claims
QUALITY · MIPS · 2024
Final MIPS score
57.3
Quality
85.3
Cost
77.1
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-2.13%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Sarah Belcher's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 8 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| SOLSTAS LAB PARTNERS GROUP LLC | 37 | 117 |
| ALLERGIC DISEASES ASTHMA & IMMUNOLOGY CLINIC PC | 35 | 94 |
| WELLMONT HEALTH SYSTEM | 17 | 25 |
| WELLMONT HEALTH SYSTEM | 11 | 16 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Marek Pienkowski Allergy/ Immunology · Knoxville, TN | 156 | 903 |
| SOLSTAS LAB PARTNERS GROUP LLC | 39 | 133 |
| WELLMONT HEALTH SYSTEM | 21 | 32 |
| MOUNTAIN STATES HEALTH ALLIANCE | 20 | 30 |
| ALLERGIC DISEASES ASTHMA & IMMUNOLOGY CLINIC PC | 20 | 44 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Burlington, NC | 14 | 25 |
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Tucker, GA | 12 | 34 |
| WELLMONT HEALTH SYSTEM | 11 | 18 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE